The spread of
Plasmodium falciparum
parasites with
Pfhrp2
/
3
gene deletions presents a major threat to reliable point-of-care diagnosis with current rapid diagnostic tests (RDTs). Novel molecular diagnostics based on nucleic acid amplification are needed to address this liability.